Science Immunology

The PDF file includes:

  • Fig. S1. Markers of complement activation are higher in COVID-19 compared to non-COVID-19 respiratory failure.
  • Fig. S2. Complement activation is associated with worse outcomes in patients with severe COVID-19.
  • Fig. S3. Components of the alternative pathway are associated with worse outcomes in COVID-19.
  • Table S1. Biospecimen reporting for improved study quality (BRISQ) Reporting Criteria.
  • Table S2. Normal values and methodology for quantifying complement analytes in plasma samples at WUSM and Yale School of Medicine.

[Download PDF]

Other Supplementary Material for this manuscript includes the following: